Health Canada reviewing safety of breastfeeding drug domperidone – National | 24CA News

Health
Published 31.01.2023
Health Canada reviewing safety of breastfeeding drug domperidone – National | 24CA News

Health Canada is conducting a security overview of domperidone given its off-label use for growing breast milk provide in postpartum ladies, the company mentioned in a press release on Tuesday.

The security overview, which began final month, is drug withdrawal signs after stopping or lowering the dose of domperidone used to stimulate lactation, Health Canada mentioned.

Read extra:

New research discovered breastfeeding infants can offset threat of bronchial asthma from antibiotics

Read subsequent:

First step or misstep? Mixed response to B.C. drug decriminalization

“Health Canada is aware that domperidone has been prescribed off-label to promote lactation in postpartum women. A safety review is currently underway,” the company mentioned.

“This safety review includes critical evaluation of information from both domestic and global post-marketing surveillance and epidemiological research to further characterize this potential safety risk. All relevant domestic and foreign case reports are being thoroughly evaluated.”

Story continues under commercial

The company famous that domperidone isn’t been approved to be used in growing lactation in Canada.


Click to play video: 'Why more awareness is needed for breastfeeding'

Why extra consciousness is required for breastfeeding


Officially, domperidone has been authorised by Health Canada for treating gastrointestinal problems since 1985.

Health Canada mentioned they’ll inform Canadians and “take appropriate action” if there are any new security dangers confirmed, including that the security overview was “prompted by domestic and foreign case reports of withdrawal symptoms after stopping or reducing the dose of domperidone used to stimulate lactation.”

Domperidone is related to potential cardiac dangers, together with sudden cardiac loss of life, Health Canada warned on its web site. The company issued two separate security alerts about domperidone and the chance of “severe irregular coronary heart rhythms and sudden loss of life (cardiac arrest) in 2012 and 2015.

— with recordsdata from Global News’ Amanda Connolly

Story continues under commercial

Have you skilled unintended effects from taking domperidone for breastfeeding in Canada? Global News desires to listen to from you. Email shareyourstory@globalnews.ca to share your expertise.

&copy 2023 Global News, a division of Corus Entertainment Inc.